National Pancreas Foundation at ASCO
On June 4-8, 2010, the American Society of Clinical Oncology convened their Annual Meeting in Chicago. This is one of the largest meetings of oncology healthcare professionals who gather to discuss the latest in cancer care.
The NPF was proud to participate in this meeting. We were able to meet with so many people who shared information about clinical trials and patient resources and much more.
Over the next few weeks we will be sharing more of this information with you. We were inspired by the dedication of these oncology professionals as they work to find new treatment options and work towards a cure.
Here are some of the poster sessions we thought you might be interested in:
- A Multi Centre Randomised Phase II Study of UFTL/Leucovorin, Radiotherapy with our without Cetuximab Following Induction Gemcitabine plus Capecitabine (GEM-CAP) in Locally Advanced Pancreatic Cancer. View Here
- Trials in Progress: A Randomized, Placebo Controlled, Multicenter Phase II Adjuvant Trial off the Efficacy, Immunogenicity, and Safety G1-4000Plus Gemcitabine Versus Gemcitabine Alone in Patients With Resected Pancreas Cancer With Activating RAS Mutations.View Here
- Apricot-P: A Phase II Randomized Placebo Controlled Study of Apricoxib , A Potent Cox-2 Inhibitor in Combination with Erlotnib and Gemcitabine in Pancreatic Cancer Patients. Coming Soon!
For more information on the thousands of abstracts that were presented at the ASCO Annual Meeting please go to:
http://chicago2010.asco.org/Home.aspx
Also visit ASCO’s patient page for oncologist approved cancer information:
http://www.cancer.net/portal/site/patient
Check back on the website often as we continue to add new content and resources!
